Importantly, the findings of higher efficiency of intracellular neutralization of RVs by the VP6-specific IgG associated with the cytosolic antibody receptor TRIM21 activity as compared to the VP6-specific IgA, confirms VP6-specific IgG protective role during infection and the VP6 as a potential vaccine target. The gene discussed is CD79A; the disease is infection.